Skip to main content

Search

SAS & Duke Health announce intended collaboration to build the AI-driven digital health care system of the future
New Cause Identified for Metabolic Disease that Strikes Native Americans
After Decades of Research, Drug Developed at Duke Receives FDA Approval
Link Between Melanoma and Estrogen Could Lead to New Therapeutic Approach
Hormone Widely Used as an Autism Treatment Shows No Benefit
Komen Initiative Awards DCI & UNC Lineberger Teams $1.5M for MBC Research
Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine
DUHS Names Accomplished Health Care Leader to Chief Operating Role
New Insight in How Breast Cancer Drug Works Could Lead to Improvements
NC InCK Launches New Model to Improve Care and Well-Being of Children Insured by Medicaid in Central NC
Duke’s School of Medicine and School of Nursing Rank in Top 10 Nationally
Cancer Repair Mechanism Could Be Potential Drug Target
Investigational Drug for Heart Failure has Little Impact on Exercise Tolerance
Investigational Anti-Clotting Drug Reduces Bleeding Risk Among AF Patients
Few Patients Have Infected Heart Devices Removed Despite Lifesaving Benefits
Duke Schools of Medicine and Nursing Rank in Top 5 for NIH Research Funding
Robert M. Califf Confirmed as Commissioner for the US Food and Drug Administration
Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
Duke Human Vaccine Institute Researchers Receive BIAL Award for Vaccine Technology
Incidence of COVID-19 was 8 Times Higher in Unvaccinated vs. Vaccinated Students